You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • P168 Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): one-year data from post-marketing surveillance in the united states

Citation Tools

Article menu
Download PDFPDF
Treating Idiopathic Pulmonary Fibrosis
P168 Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): one-year data from post-marketing surveillance in the united states

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Maher T, Noth I, Allinger A, et al
P168 Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): one-year data from post-marketing surveillance in the united states
Thorax 2016;71:A175.